IGF-1 induces human myotube hypertrophy by increasing cell recruitment

Exp Cell Res. 2004 Sep 10;299(1):148-58. doi: 10.1016/j.yexcr.2004.05.023.

Abstract

Insulin-like growth factor-1 (IGF-1) has been shown in rodents (i) in vivo to induce muscle fiber hypertrophy and to prevent muscle mass decline with age and (ii) in vitro to enhance the proliferative life span of myoblasts and to induce myotube hypertrophy. In this study, performed on human primary cultures, we have shown that IGF-1 has very little effect on the proliferative life span of human myoblasts but does delay replicative senescence. IGF-1 also induces hypertrophy of human myotubes in vitro, as characterized by an increase in the mean number of nuclei per myotube, an increase in the fusion index, and an increase in myosin heavy chain (MyHC) content. In addition, muscle hypertrophy can be triggered in the absence of proliferation by recruiting more mononucleated cells. We propose that IGF-1-induced hypertrophy can involve the recruitment of reserve cells in human skeletal muscle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Aged
  • Cell Division / drug effects
  • Cell Division / physiology
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Cell Nucleus / ultrastructure
  • Cells, Cultured
  • Cellular Senescence / drug effects
  • Cellular Senescence / physiology
  • Humans
  • Hypertrophy / chemically induced
  • Hypertrophy / metabolism*
  • Infant, Newborn
  • Insulin-Like Growth Factor I / metabolism*
  • Insulin-Like Growth Factor I / pharmacology
  • Membrane Fusion / drug effects
  • Membrane Fusion / physiology
  • Muscle Fibers, Skeletal / cytology
  • Muscle Fibers, Skeletal / drug effects
  • Muscle Fibers, Skeletal / metabolism*
  • Muscle, Skeletal / cytology
  • Muscle, Skeletal / growth & development*
  • Muscle, Skeletal / metabolism*
  • Myosin Heavy Chains / drug effects
  • Myosin Heavy Chains / metabolism
  • Satellite Cells, Skeletal Muscle / drug effects
  • Up-Regulation / drug effects
  • Up-Regulation / physiology

Substances

  • Insulin-Like Growth Factor I
  • Myosin Heavy Chains